Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/3759 stock hub

HKG/3759 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/3759is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

53.1B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/3759

In the news

Latest news · HKG/3759

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.6

P25 11.7P50 18.9P75 41.4

Trailing P/E27.6

P25 10.7P50 17.9P75 38.5

ROE10

P25 -14.7P50 2P75 9.4

ROIC8.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/3759 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	25,088
Employees Change	3,718%
Employees Change Percent	17.4
Enterprise value	HKD 58.6B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100003PG4
Last refreshed	2026-05-10
Market cap	HKD 53.1B
Price	HKD 19.34
Price currency	HKD
Rev Per Employee	660,338.61x
Sector	Healthcare
Sic	8731
Symbol	hkg/3759
Website	https://www.pharmaron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.63%
EV Earnings	30.44x
EV/EBIT	24.56x
EV/EBITDA	15.57x
EV/FCF	184.01x
EV/Sales	3.49x
FCF yield	0.6%
Forward P/E	20.65x
P/B ratio	2.73x
P/E ratio	27.58x
P/S ratio	3.21x
PE Ratio10 Y	54.34x
PE Ratio3 Y	27.15x
PE Ratio5 Y	44.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.22%
EBITDA Margin	21.35%
FCF margin	1.92%
Gross margin	34.38%
Gross Profit	HKD 5.7B
Gross Profit Growth	15.04%
Gross Profit Growth Q	11.5%
Gross Profit Growth3 Y	7.41%
Gross Profit Growth5 Y	18.82%
Net Income	HKD 1.9B
Net Income Growth	-9.35%
Net Income Growth Q	9.75%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	4.75%
Net Income Growth5 Y	5.16%
Pretax Margin	13.46%
Profit Margin	11.62%
Profit Per Employee	HKD 76,736
Profitable Years	12
ROA	4.9
Roa5y	5.02
ROCE	10.27
ROE	9.99
Roe5y	13.13
ROIC	8.1
Roic5y	10.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	44.34%
Cagr3y	-3.14%
Cagr5y	-21.16%
Div CAGR3	-12.68%
Div CAGR5	6.3%
EPS Growth	-10.05
EPS Growth Q	6.75
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	4.55
EPS Growth5 Y	5.19
FCF Growth	-52.2%
FCF Growth Q	-91.49%
FCF Growth5 Y	17.58%
OCF Growth	10.76%
OCF Growth Q	-29.13%
OCF Growth3 Y	9.65%
OCF Growth5 Y	10.29%
Revenue Growth	14.73x
Revenue Growth Q	15.48x
Revenue Growth Quarters	8x
Revenue Growth Years	11x
Revenue Growth3 Y	10.21x
Revenue Growth5 Y	20.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.55
Assets	HKD 32.5B
Cash	HKD 3.4B
Current Assets	HKD 10.4B
Current Liabilities	HKD 9.6B
Debt	HKD 8.1B
Debt EBITDA	HKD 2.17
Debt Equity	HKD 0.41
Debt FCF	HKD 25.35
Equity	HKD 19.5B
Interest Coverage	10.34
Liabilities	HKD 13B
Long Term Assets	HKD 22B
Long Term Liabilities	HKD 3.4B
Net Cash	HKD -4.7B
Net Cash By Market Cap	HKD -8.83
Net Debt EBITDA	HKD 1.33
Net Debt Equity	HKD 0.24
Net Debt FCF	HKD 14.72
Tangible Book Value	HKD 13.4B
Tangible Book Value Per Share	HKD 7.3
WACC	7.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.08
Inventory Turnover	6.69
Net Working Capital	HKD 2.9B
Quick ratio	0.75
Working Capital	HKD 773.2M
Working Capital Turnover	HKD 8.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.78%
Dividend Growth	-0.51%
Dividend Growth Years	0%
Dividend per share	HKD 0.22
Dividend Years	6
Dividend Yield	1.08%
Ex Div Date	2025-07-04
Last Dividend	HKD 0.22
Payout Frequency	Annual
Payout Ratio	31.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	44.3%
200-day SMA	22.04
3Y total return	-9.13%
50-day SMA	19.85
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.54%
All Time High	94.22
All Time High Change	-79.47%
All Time High Date	2021-07-02
All Time Low	7.98
All Time Low Change	142.36%
All Time Low Date	2024-07-09
ATR	1.04
Beta	0.83
Ch YTD	-1.28
High	20.2
High52	30.12
High52 Date	2025-10-02
High52ch	-35.79%
Low	18.96
Low52	12.88
Low52 Date	2025-05-19
Low52ch	50.16%
Ma50ch	-2.59%
Price vs 200-day SMA	-12.25%
RSI	40.26
RSI Monthly	49.51
RSI Weekly	45.18
Sharpe ratio	0.85x
Sortino ratio	1.47
Total Return	0.3%
Tr YTD	-1.28
Tr1m	-7.82%
Tr1w	-8.69%
Tr3m	-7.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 2.4B
Operating Income Growth	12.25
Operating Income Growth Q	6.35
Operating Income Growth3 Y	5.26
Operating Income Growth5 Y	12.26
Operating margin	14.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,260,371,742%
Net Borrowing	1,067,257,544.2
Shares Insiders	7.57%
Shares Institutions	21.14%
Shares Qo Q	1.1%
Shares Yo Y	0.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 318.4M
Average Volume	5,827,281.85x
Bv Per Share	10.22
CAPEX	HKD -3.1B
Ch1m	-7.82
Ch1w	-8.69
Ch1y	42.42
Ch3m	-7.2
Ch3y	-13.53
Ch5y	-71.24
Ch6m	-18.6
Change	-3.97%
Change From Open	-4.26
Close	20.14
Days Gap	0.3
Depreciation Amortization	1,196,129,761
Dollar Volume	145,034,528
Earnings Date	2026-04-29
EBIT	HKD 2.4B
EBITDA	HKD 3.5B
EPS	HKD 1.08
F Score	7
FCF	HKD 318.4M
FCF EV Yield	0.54x
Financing CF	1,797,746,362
Fiscal Year End	December
Founded	2,004
Goodwill	4,070,875,929.7
Graham Number	10.57354
Graham Upside	-45.33
Income Tax	HKD 427.3M
Investing CF	-3,870,313,757
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2023-07-18
Last Split Type	Forward
Lynch Fair Value	HKD 3.62
Lynch Upside	-81.28
Ma150	21.88
Ma150ch	-11.62%
Ma20	20.92
Ma20ch	-7.54%
Net CF	1,265,741,105
Next Earnings Date	2026-08-24
Open	20.2
P FCF Ratio	166.7
P OCF Ratio	15.71
Payment Date	2025-08-06
Position In Range	30.65
Ppne	14,042,694,181
Price Date	2026-05-08
Price EBITDA	HKD 15.01
Ptbv Ratio	3.97
Relative Volume	1.31x
Revenue	16,566,575,079x
Tax By Revenue	2.58x
Tax Rate	19.16%
Tr6m	-18.6%
Volume	7,499,200
Z Score	3.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/3759 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.22 annual per share

Payout ratio

+31.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.3%

0 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-07-04

Performance

HKG/3759 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/3759?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.1%

Share of float held by funds and institutions

Insider ownership

+7.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

HKG/3759 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.3

Neutral momentum band

Price vs 200-day MA

-12.3%

50/200-day relationship not available

Beta (5Y)

0.83

Moves roughly with the market

Sharpe ratio

0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/3759

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/3759 stock rating?

hkg/3759 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/3759 analysis?

The full report lives at /stocks/hkg/3759/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/3759?

The latest report frames hkg/3759 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/3759 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.